Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Involvement of the basal forebrain and hippocampus in memory deficits in Parkinson's disease.
Sakamaki-Tsukita H, Shima A, Kambe D, Furukawa K, Nishida A, Wada I, Yoshimura K, Sakato Y, Terada Y, Yamakado H, Taruno Y, Nakanishi E, Sawamura M, Fushimi Y, Okada T, Nakamoto Y, Zaborszky L, Takahashi R, Sawamoto N. Sakamaki-Tsukita H, et al. Among authors: taruno y. Parkinsonism Relat Disord. 2024 Nov;128:107134. doi: 10.1016/j.parkreldis.2024.107134. Epub 2024 Sep 10. Parkinsonism Relat Disord. 2024. PMID: 39293154 Free article.
Minimum and early high-energy sonication protocol of MR-guided focused ultrasound thalamotomy for low-skull density ratio patients with essential tremor and Parkinson's disease.
Nishida N, Sugita Y, Sawada M, Ishimori T, Taruno Y, Otsuki K, Motoie R, Kitamura K, Yoshizaki W, Kasashima K, Sugiyama J, Yamashita M, Hanyu T, Takahashi M, Kaneko S, Toda H. Nishida N, et al. Among authors: taruno y. Neurosurg Focus. 2024 Sep 1;57(3):E4. doi: 10.3171/2024.6.FOCUS24330. Neurosurg Focus. 2024. PMID: 39217631
Frontoparietal-Striatal Network and Nucleus Basalis Modulation in Patients With Parkinson Disease and Gait Disturbance.
Nishida A, Shima A, Kambe D, Furukawa K, Sakamaki-Tsukita H, Yoshimura K, Wada I, Sakato Y, Terada Y, Sawamura M, Nakanishi E, Taruno Y, Yamakado H, Fushimi Y, Okada T, Nakamoto Y, Takahashi R, Sawamoto N. Nishida A, et al. Among authors: taruno y. Neurology. 2024 Aug 13;103(3):e209606. doi: 10.1212/WNL.0000000000209606. Epub 2024 Jul 8. Neurology. 2024. PMID: 38976821
Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study.
Nishikawa N, Murata M, Hatano T, Mukai Y, Saitoh Y, Sakamoto T, Hanakawa T, Kamei Y, Tachimori H, Hatano K, Matsuda H, Taruno Y, Sawamoto N, Kajiyama Y, Ikenaka K, Kawabata K, Nakamura T, Iwaki H, Kadotani H, Sumi Y, Inoue Y, Hayashi T, Ikeuchi T, Shimo Y, Mochizuki H, Watanabe H, Hattori N, Takahashi Y, Takahashi R; Japan Parkinson's Progression Markers Initiative (J-PPMI) study group. Nishikawa N, et al. Among authors: taruno y. Parkinsonism Relat Disord. 2022 Oct;103:129-135. doi: 10.1016/j.parkreldis.2022.08.011. Epub 2022 Sep 8. Parkinsonism Relat Disord. 2022. PMID: 36113390
Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease.
Furukawa K, Shima A, Kambe D, Nishida A, Wada I, Sakamaki H, Yoshimura K, Terada Y, Sakato Y, Mitsuhashi M, Sawamura M, Nakanishi E, Taruno Y, Yamakado H, Fushimi Y, Okada T, Nakamoto Y, Takahashi R, Sawamoto N. Furukawa K, et al. Among authors: taruno y. Ann Neurol. 2022 Jul;92(1):110-121. doi: 10.1002/ana.26373. Epub 2022 May 2. Ann Neurol. 2022. PMID: 35428994
Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations.
Kondo T, Banno H, Okunomiya T, Amino Y, Endo K, Nakakura A, Uozumi R, Kinoshita A, Tada H, Morita S, Ishikawa H, Shindo A, Yasuda K, Taruno Y, Maki T, Suehiro T, Mori K, Ikeda M, Fujita K, Izumi Y, Kanemaru K, Ishii K, Shigenobu K, Kutoku Y, Sunada Y, Kawakatsu S, Shiota S, Watanabe T, Uchikawa O, Takahashi R, Tomimoto H, Inoue H. Kondo T, et al. Among authors: taruno y. BMJ Open. 2021 Jun 30;11(6):e051343. doi: 10.1136/bmjopen-2021-051343. BMJ Open. 2021. PMID: 34193504 Free PMC article. Clinical Trial.
Perampanel Inhibits α-Synuclein Transmission in Parkinson's Disease Models.
Ueda J, Uemura N, Sawamura M, Taguchi T, Ikuno M, Kaji S, Taruno Y, Matsuzawa S, Yamakado H, Takahashi R. Ueda J, et al. Among authors: taruno y. Mov Disord. 2021 Jul;36(7):1554-1564. doi: 10.1002/mds.28558. Epub 2021 Apr 4. Mov Disord. 2021. PMID: 33813737 Free article.
14 results